Novo CEO signals M&A opportunities to strengthen drug pipeline

CNBC•Tue, Sep 22, 2026, 09:39 AM•2 min read

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Source: [CNBC](https://www.cnbc.com/2026/09/22/novo-nordisk-ceo-interview-weight-loss-drugs-strategy.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at CNBC ↗

#finance #novo #ceo #opportunities #signals #strengthen #drug #pipeline #mike

More Headlines

FinanceSeeking Alpha• 11m ago

Why Today's Nasdaq Doesn't Look Like 2000, Even With AI Fears Rising

Developing story — details emerging. Check the source link for the latest updates.

FinanceYahoo Finance• 13m ago

Whitbread initiates 180-room hotel development in Vauxhall, London

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 15m ago

U.S. threatens to 'shut down' Iranian airlines as Houthis tighten pressure on oil route

The Treasury Secretary said that Washington was pressuring Iran "like never before"

FinanceYahoo Finance• 16m ago

Prediction: A Stock Market Crash Is Coming. Here's What Investors Should Do Based on Almost 70 Years' Worth of History.

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 16m ago

Oil Drops as Traders Track Hormuz Diplomacy Prospects

Brent fell toward $99 a barrel, after tumbling over the previous four sessions. Oil erased earlier gains on a report that Iran could reopen the Strait of Hormuz if the US lifted a blockade of its ports. US President Donald Trump is set to address the United Nations General Assembly in New York ...

FinanceYahoo Finance• 16m ago

Aecon-led JV secures $2.1bn contracts for Ontario’s Pickering nuclear refurbishment

Developing story — details emerging. Check the source link for the latest updates.